top of page

Aplastic anaemia (bone marrow failure)

Aplastic anaemia (bone marrow failure)
Aplastic anaemia (bone marrow failure)
Aplastic anaemia (bone marrow failure)
Aplastic anaemia (bone marrow failure)

Introduction

Aplastic anaemia is defined as pancytopenia resulting from aplasia of the bone marrow Pancytopenia – a reduction in the blood count of all the major cell lines

Causes of aplastic anaemia

Primary

• Congenital (Fanconi and non-fanconi
• Idiopathic acquired

Secondary

• Ionozing radiation: Accidental exposure (radiotherapy, radioactive isotopes, nuclear power stations
• Chemicals: Benzene, DDT, insecticides T lymphocyte mediated autoimmune suppression of haemopoietic stem cell
• Drugs esp: chloramphenical Infections esp viral hepatitis (A or non-A Connective tissue diseases, pregnancy

Risk Factors

Signs and symptoms

Vary with severity but include;
• Anaemia
• Easy bruising/bleeding
• Recurrent infection
• Splenomegaly is not a feature.

Diagnostic criteria

• Pancytopenia
• Bone marrow hypocellularity of < 30% hematopoietic cells for children and young adults
• Confirmed by trephine biopsy.

Classification by severity of Aplastic Anaemia (AA)

Severe AA (SAA)

For SAA at least two of the following three criteria have to be fulfilled:
• Reticulocytes <60x109/L (using an automated analyzer) or < 20 x 109/l (manual count) Platelets < 20x109/L Absolute neutrophils <0.5 x109/L

Very severe AA (vSAA)

• For vSAA, the same criteria of SAA have to be fulfilled; however the absolute neutrophil count has to be < 0.2 x109/l

Moderate Aplastic Anaemia (AA)

• Moderate AA is considered when the severity criteria of SAA are not fulfilled

Investigations

Treatment

  • Non-pharmacological

  • Pharmacological

Prevention

Updated on,

14 Novemba 2020 11:47:51

References

    1. STG
bottom of page